(Total Views: 230)
Posted On: 04/07/2018 3:39:26 PM
Post# of 72444
I always thought the name Cellceutix was not good. It's hard to pronounce for starters, and it's -- what? "Cell" combined with "therapeutics" or something? I'm really glad they changed it. I'm sure I'm not the only one who thinks it was hard to say.
Plus a name like that kind of makes me think of a company that is focused on diagnostic studies at cellular level, or something like that, rather than on developing drugs that may be used topically (e.g. Brilacidin for dermatitis etc.) or for broad systemic changes for auto-immune disease, like Prurisol. Kevetrin is kind of the only drug that fits for a company with "cell" in its name, since we're talking there about something that re-activates p53 within cells.
But that's just me.
Plus a name like that kind of makes me think of a company that is focused on diagnostic studies at cellular level, or something like that, rather than on developing drugs that may be used topically (e.g. Brilacidin for dermatitis etc.) or for broad systemic changes for auto-immune disease, like Prurisol. Kevetrin is kind of the only drug that fits for a company with "cell" in its name, since we're talking there about something that re-activates p53 within cells.
But that's just me.
(2)
(0)
